Antex Biologics (ANTX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX)

ANTX 1.070

-2.3%

Nov 26 3:58 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ted Downs who wrote (640)	1/5/1998 3:41:00 PM
From: Christopher Horner	Read Replies (1) of 1476

Stock is up nicely today on good volume. Wonder what's up.?? I spoke to Terry Smith today. Following is brief resume of conversation: 1) Company is determined to get at least small-cap listing this year. Dr. E is constantly travelling to speak about antx to analysts, brokers etc, very few of whom are able to take positions at this level. Sorta the same old story, except that more investors (incl. institutional ones) are now following the company. Should translate into a bigger pop once the stock starts moving and/or major news starts flowing. 2) Campy on track to wrap up phase 2 in 1st qtr. '98 3) Helico on track to wrap up phase 1 in 2nd qtr '98 4) Influenza currently in phase 1b at pasteur-merieux. I didn't realize that p-m is actually doing the clinical work on this one. Antx gets milestone payments and will get royalties if/when a vaccine is commercialized. Antex owns patents, but has licensed them outright to p-m. 5) Terry suggested Antx will be taking a higher public profile in '98 and that we'll see evidence of that in next few weeks. No specifics were given...we'll see 6) Re quietness on recent granted patent: Terry said patent was one of 3 already announced earlier last year as being assigned to Antex by US patent office. Company felt it'd be redundant to announce this again. Even though previously announced, this situation is typical of the company's low-profile approach as GRANTING of patent is different from ASSIGNMENT of patent, it seems to me... That's it for now. Nothing earthshaking, except perhaps the "higher profile" possibility. Just solid progress which hopefully will translate into good clinical results --and a slow, steady climb in stock price...or maybe not so slow, given today's action!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next